This brokerage stock is 50% cheaper than Robinhood. Josh Brown sees an opportunity to buy the dip — Positive
HOOD CNBC — October 23, 2025Josh and Sean trade an under-the-radar brokerage stock that's in all the same markets as Robinhood.
Snowflake (NYSE: SNOW) Price Prediction and Forecast 2025-2030 (November 2025) — Positive
SNOW 24/7 Wall Street — October 23, 2025Shares of cloud-based storage solutions provider Snowflake Inc. (NYSE: SNOW) surged 11.97% over the past month after gaining 15.35% the month prior.
United Rentals' Q3 Earnings Miss Estimates, Revenues Up Y/Y — Negative
URI Zacks Investment Research — October 23, 2025URI posts record third-quarter revenues and adjusted EBITDA on solid construction demand, but earnings fall short of estimates.
How Will Ozempic and Wegovy Sales Aid NVO's Upcoming Q3 Results? — Negative
NVO Zacks Investment Research — October 23, 2025Novo Nordisk's Q3 results hinge on Ozempic and Wegovy sales as demand growth slows amid rivalry, market limits and compounded drug headwinds.
Wall Street Analysts See a 37.48% Upside in Elastic (ESTC): Can the Stock Really Move This High? — Positive
ESTC Zacks Investment Research — October 23, 2025The average of price targets set by Wall Street analysts indicates a potential upside of 37.5% in Elastic (ESTC). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Here's Why United Natural (UNFI) Looks Ripe for Bottom Fishing — Neutral
UNFI Zacks Investment Research — October 23, 2025United Natural (UNFI) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
How Much Upside is Left in Castle Biosciences (CSTL)? Wall Street Analysts Think 50.08% — Positive
CSTL Zacks Investment Research — October 23, 2025The consensus price target hints at a 50.1% upside potential for Castle Biosciences (CSTL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Verastem (VSTM) Forms 'Hammer Chart Pattern': Time for Bottom Fishing? — Neutral
VSTM Zacks Investment Research — October 23, 2025After losing some value lately, a hammer chart pattern has been formed for Verastem (VSTM), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Does Allied Gold Corporation (AAUC) Have the Potential to Rally 48.21% as Wall Street Analysts Expect? — Positive
AAUC Zacks Investment Research — October 23, 2025The mean of analysts' price targets for Allied Gold Corporation (AAUC) points to a 48.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Does a.k.a. Brands (AKA) Have the Potential to Rally 48.44% as Wall Street Analysts Expect? — Positive
AKA Zacks Investment Research — October 23, 2025The consensus price target hints at a 48.4% upside potential for a.k.a. Brands (AKA).
Can Alto Neuroscience, Inc. (ANRO) Climb 27.45% to Reach the Level Wall Street Analysts Expect? — Positive
ANRO Zacks Investment Research — October 23, 2025The consensus price target hints at a 27.5% upside potential for Alto Neuroscience, Inc. (ANRO). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Allstate (ALL) Forms 'Hammer Chart Pattern': Time for Bottom Fishing? — Neutral
ALL Zacks Investment Research — October 23, 2025After losing some value lately, a hammer chart pattern has been formed for Allstate (ALL), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Wall Street Analysts See a 108.23% Upside in Lexeo Therapeutics, Inc. (LXEO): Can the Stock Really Move This High? — Positive
LXEO Zacks Investment Research — October 23, 2025The consensus price target hints at a 108.2% upside potential for Lexeo Therapeutics, Inc. (LXEO). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Wall Street Analysts Believe Vertex (VERX) Could Rally 44.47%: Here's is How to Trade — Positive
VERX Zacks Investment Research — October 23, 2025The mean of analysts' price targets for Vertex (VERX) points to a 44.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Quantum Computing Stocks Rally on Government Stake Talks — Positive
IONQ QBTS QUBT RGTI Schaeffers Research — October 23, 2025Quantum computing stocks have lost a little luster lately, as Wall Street catches up to their valuations.
Quantum computing firms surge as Trump administration reportedly explore equity stakes — Positive
IONQ QBTS RGTI Proactive Investors — October 23, 2025The Trump administration is in discussions with several quantum computing companies about taking equity stakes in exchange for federal funding, according to a Wall Street Journal report. Companies involved in the talks include IonQ (NYSE:IONQ), Rigetti Computing (NASDAQ:RGTI), and D-Wave Quantum (NYSE:QBTS), while others such as Quantum Computing Inc. (OTCQB:QUBT) and Atom Computing are considering similar arrangements, according to the Journal, citing anonymous sources familiar with the matter.
Kadant to Hold Earnings Conference Call on Wednesday, October 29, 2025 — Neutral
KAI GlobeNewsWire — October 23, 2025WESTFORD, Mass., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Kadant Inc. (NYSE: KAI) announced it will release its 2025 third quarter results after the market closes on Tuesday, October 28, 2025 and will hold a webcast the next day, Wednesday, October 29, 2025 at 11:00 a.m. Eastern Time. During the call the Company will discuss its third quarter financial performance and future expectations.
Entergy Gears Up to Report Q3 Earnings: Here's What to Expect — Positive
ETR Zacks Investment Research — October 23, 2025ETR's Q3 results may reflect higher power demand and key grid upgrades, though rising costs could temper gains.
Hexcel's Q3 Earnings Miss Estimates, Sales Beat, '25 EPS View Lowered — Negative
HXL Zacks Investment Research — October 23, 2025HXL's Q3 earnings lag estimates despite a slight sales beat, as weaker aerospace demand and margin pressure lead to a lowered 2025 EPS outlook.
Lam Research Q1 Earnings Surpass Expectations, Revenues Rise Y/Y — Positive
LRCX Zacks Investment Research — October 23, 2025LRCX's Q1 earnings and revenues surpass forecasts, boosted by strong systems sales and rising demand across key Asian markets.
